EHC - Encompass Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.11B
Enterprise Value 39.6B
Trailing P/E 19.93
Forward P/E 116.85
PEG Ratio (5 yr expected) 11.68
Price/Sales (ttm)1.38
Price/Book (mrq)4.79
Enterprise Value/Revenue 32.17
Enterprise Value/EBITDA 610.63

Trading Information

Stock Price History

Beta (3Y Monthly) 1.31
52-Week Change 3-25.67%
S&P500 52-Week Change 3-0.33%
52 Week High 382.46
52 Week Low 356.74
50-Day Moving Average 363.70
200-Day Moving Average 362.29

Share Statistics

Avg Vol (3 month) 3724.65k
Avg Vol (10 day) 3438.86k
Shares Outstanding 598.85M
Float 97.15M
% Held by Insiders 11.23%
% Held by Institutions 192.42%
Shares Short (Jul 31, 2019) 42.14M
Short Ratio (Jul 31, 2019) 42.84
Short % of Float (Jul 31, 2019) 42.19%
Short % of Shares Outstanding (Jul 31, 2019) 42.17%
Shares Short (prior month Jun 28, 2019) 41.94M

Dividends & Splits

Forward Annual Dividend Rate 41.12
Forward Annual Dividend Yield 41.85%
Trailing Annual Dividend Rate 31.08
Trailing Annual Dividend Yield 31.78%
5 Year Average Dividend Yield 41.96
Payout Ratio 434.73%
Dividend Date 3Oct 15, 2019
Ex-Dividend Date 4Sep 30, 2019
Last Split Factor (new per old) 25/1
Last Split Date 3Oct 26, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 7.01%
Operating Margin (ttm)15.69%

Management Effectiveness

Return on Assets (ttm)7.95%
Return on Equity (ttm)21.43%

Income Statement

Revenue (ttm)4.42B
Revenue Per Share (ttm)45.11
Quarterly Revenue Growth (yoy)6.30%
Gross Profit (ttm)1.76B
EBITDA 903.1M
Net Income Avi to Common (ttm)308.4M
Diluted EPS (ttm)3.11
Quarterly Earnings Growth (yoy)-0.70%

Balance Sheet

Total Cash (mrq)221.7M
Total Cash Per Share (mrq)2.25
Total Debt (mrq)3.05B
Total Debt/Equity (mrq)157.43
Current Ratio (mrq)1.12
Book Value Per Share (mrq)12.94

Cash Flow Statement

Operating Cash Flow (ttm)682.2M
Levered Free Cash Flow (ttm)464.36M